Puma Biotechnology, Inc. (PBYI)
10.76
+0.55
(+5.39%)
USD |
NASDAQ |
Oct 20, 16:00
11.11
+0.35
(+3.25%)
After-Hours: 07:08
Puma Biotechnology Gross Profit (TTM) : 173.04M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 173.04M |
| March 31, 2026 | 169.15M |
| December 31, 2025 | 170.21M |
| September 30, 2025 | 163.04M |
| June 30, 2025 | 172.19M |
| March 31, 2025 | 168.48M |
| December 31, 2024 | 166.06M |
| September 30, 2024 | 168.76M |
| June 30, 2024 | 160.15M |
| March 31, 2024 | 166.44M |
| December 31, 2023 | 172.96M |
| September 30, 2023 | 173.94M |
| June 30, 2023 | 175.71M |
| March 31, 2023 | 177.60M |
| December 31, 2022 | 172.94M |
| September 30, 2022 | 167.60M |
| June 30, 2022 | 158.96M |
| March 31, 2022 | 155.77M |
| December 31, 2021 | 189.49M |
| September 30, 2021 | 187.69M |
| June 30, 2021 | 192.54M |
| March 31, 2021 | 212.29M |
| December 31, 2020 | 185.82M |
| September 30, 2020 | 196.92M |
| June 30, 2020 | 203.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 186.52M |
| December 31, 2019 | 235.46M |
| September 30, 2019 | 243.46M |
| June 30, 2019 | 250.06M |
| March 31, 2019 | 247.40M |
| December 31, 2018 | 216.45M |
| September 30, 2018 | 173.15M |
| June 30, 2018 | 124.12M |
| March 31, 2018 | 81.91M |
| December 31, 2017 | 21.50M |
| September 30, 2017 | 3.416M |
| June 30, 2017 | -1.245M |
| March 31, 2017 | -1.218M |
| December 31, 2016 | -1.149M |
| September 30, 2016 | -0.773M |
| June 30, 2016 | -0.862M |
| March 31, 2016 | -0.804M |
| December 31, 2015 | -0.776M |
| September 30, 2015 | -0.757M |
| June 30, 2015 | -0.717M |
| March 31, 2015 | -0.674M |
| December 31, 2014 | -0.627M |
| September 30, 2014 | -0.563M |
| June 30, 2014 | -0.513M |
| March 31, 2014 | -0.466M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Anika Therapeutics, Inc. | 75.00M |
| Arcutis Biotherapeutics, Inc. | 422.88M |
| Olema Pharmaceuticals, Inc. | -0.451M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |